silybin has been researched along with Fibrosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Bartalis, J; Halaweish, FT | 1 |
| Chen, JJ; Dong, W; Geng, CA; He, XF; Huang, XY; Li, TZ; Zhang, XM | 1 |
| Liu, J; Liu, K; Liu, M; Wang, Y; Zhou, S; Zhu, F | 1 |
| Ma, Z; Wang, H; Wei, X; Zang, W | 1 |
| Ding, Z; Li, Y; Liu, R; Wang, Q; Zang, Y; Zhang, G; Zhang, X | 1 |
| Chen, J; Chen, Z; Yang, XD; Yang, YY; Ye, L | 1 |
| Cho, YK; Kim, HJ; Kim, JC; Ko, JW; Lee, IC; Park, SH; Ryu, JM; Shin, IS; Shin, NR | 1 |
| Chang, YH; Chen, CL; Chen, JT; Chen, YH; Chien, KH; Liang, CM; Lu, DW; Tai, MC | 1 |
| Ai, W; Bai, X; Bian, ZY; Huang, H; Li, H; Liu, C; Tang, QZ; Yan, L; Yin, L; Zhang, Y | 1 |
9 other study(ies) available for silybin and Fibrosis
| Article | Year |
|---|---|
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
Topics: Animals; Cell Line; Cell Proliferation; Cucurbitacins; Fibrosis; Hep G2 Cells; Hepatic Stellate Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver; Protective Agents; Quantitative Structure-Activity Relationship; Rats | 2011 |
Artemzhongdianolides A1-A21, antihepatic fibrosis guaiane-type sesquiterpenoid dimers from Artemisia zhongdianensis.
Topics: Artemisia; Fibrosis; Humans; Molecular Structure; Sesquiterpenes; Sesquiterpenes, Guaiane; Silybin | 2022 |
Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy.
Topics: Animals; Apoptosis; Cell Survival; Diabetic Nephropathies; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Fibrosis; Humans; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Silybin; Transforming Growth Factor beta1 | 2019 |
Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-β signaling pathway.
Topics: Down-Regulation; Drug Therapy, Combination; Fibrosis; Gene Expression; Humans; In Vitro Techniques; Kidney; Lisinopril; Signal Transduction; Silybin; Transforming Growth Factor beta | 2020 |
Silibinin Augments the Antifibrotic Effect of Valsartan Through Inactivation of TGF-β1 Signaling in Kidney.
Topics: Animals; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Drug Synergism; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Renal Insufficiency, Chronic; Signal Transduction; Silybin; Transforming Growth Factor beta1; Valsartan | 2020 |
Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Survival; Choline Deficiency; Cytokines; Esculin; Fatty Acids, Nonesterified; Fibrosis; Hep G2 Cells; Hepatocytes; Humans; Inflammation; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Models, Animal; NF-kappa B; Non-alcoholic Fatty Liver Disease; RNA, Small Interfering; Signal Transduction; Silybin; Sirtuin 1 | 2021 |
Silibinin inhibits the fibrotic responses induced by cigarette smoke via suppression of TGF-β1/Smad 2/3 signaling.
Topics: Animals; Fibrosis; Humans; Male; Mice, Inbred C57BL; Nicotiana; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Silybin; Silymarin; Smad2 Protein; Smad3 Protein; Smoking; Transforming Growth Factor beta1 | 2017 |
Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
Topics: Actins; Animals; Antioxidants; Blotting, Western; Cell Movement; Cell Transdifferentiation; Collagen Type I; Connective Tissue Growth Factor; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibrosis; Humans; Myofibroblasts; Rabbits; Receptors, Transforming Growth Factor beta; Silybin; Silymarin; Tenon Capsule; Trabecular Meshwork; Trabeculectomy; Transforming Growth Factor beta1; Vimentin | 2013 |
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Cardiomegaly; Cell Shape; Cells, Cultured; Dose-Response Relationship, Drug; ErbB Receptors; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Silybin; Silymarin | 2010 |